Stocks / AMGN
AMGN stock forecast
AMGEN INC · Healthcare · Drug Manufacturers - General
The model's rating
Outperform
AMGN is rated Outperform as of September 29, 2026: its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth.
Changed from Greatly Outperform on September 28, 2026.
Create a free account to compare any two stocks; the numeric score is part of Premium.
AMGN is not among the 20 largest holdings published for 2026 Q4. See the portfolio
AMGN against the S&P 500
| Period | AMGN | S&P 500 (SPY) |
|---|---|---|
| 1 month | -1.9% | -0.3% |
| 3 months | +17.3% | +2.5% |
| Year to date | +31.4% | +12.7% |
| 1 year | +53.5% | +15.7% |
Total return, dividends included.
Key numbers
| Price | $421.51 |
| Market cap | 227.88 Billion |
| P/E (trailing 12 months) | 26.0 |
| P/S (trailing 12 months) | 6.0 |
| P/B (latest quarter) | 18.9 |
| Gross margin | 69.5% |
| Net profit margin | 23.0% |
| Return on equity | 89.3% |
| Beta | 0.5 |
As of August 5, 2026.
AMGN and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | 184.82 Billion | Outperform | AMGN vs GILD |
| PFE | PFIZER INC | 162.55 Billion | Greatly Outperform | AMGN vs PFE |
| BMY | BRISTOL MYERS SQUIBB CO | 127.47 Billion | Outperform | AMGN vs BMY |
| MRK | MERCK & CO INC | 358.5 Billion | Greatly Outperform | MRK vs AMGN |
| BIIB | BIOGEN INC | 33.37 Billion | Outperform | |
| ABBV | ABBVIE INC | 462.26 Billion | Outperform | ABBV vs AMGN |
Questions
What does the Upfront Investment model say about AMGN?
The model rates AMGEN INC (AMGN) "Outperform" as of September 29, 2026, which means its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the AMGN rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is AMGN in the Upfront Investment model portfolio?
AMGN is not among the 20 largest holdings published for 2026 Q4.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.